Hallgreen CE - Search Results

1

Mandatory requirements for pediatric drug development in the EU and the US for novel drugs-A comparative study.

Christiansen H, De Bruin ML, Hallgreen CE. Christiansen H, et al. Among authors: hallgreen ce. Front Med (Lausanne). 2022 Oct 31;9:1009432. doi: 10.3389/fmed.2022.1009432. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36388912 Free PMC article.

2

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.

Hallgreen CE, van den Ham HA, Mt-Isa S, Ashworth S, Hermann R, Hobbiger S, Luciani D, Micaleff A, Thomson A, Wang N, van Staa TP, Downey G, Hirsch I, Hockley K, Juhaeri J, Metcalf M, Mwangi J, Nixon R, Peters R, Stoeckert I, Waddingham E, Tzoulaki I, Ashby D, Wise L. Hallgreen CE, et al. Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):974-83. doi: 10.1002/pds.3676. Epub 2014 Jul 5. Pharmacoepidemiol Drug Saf. 2014. PMID: 25043919 Free article.

3

Allometric relationship between changes of visceral fat and total fat mass.

Hallgreen CE, Hall KD. Hallgreen CE, et al. Int J Obes (Lond). 2008 May;32(5):845-52. doi: 10.1038/sj.ijo.0803783. Epub 2007 Dec 18. Int J Obes (Lond). 2008. PMID: 18087265 Free PMC article.

4

Increasing weight loss attenuates the preferential loss of visceral compared with subcutaneous fat: a predicted result of an allometric model.

Hall KD, Hallgreen CE. Hall KD, et al. Among authors: hallgreen ce. Int J Obes (Lond). 2008 Apr;32(4):722. doi: 10.1038/ijo.2008.14. Epub 2008 Feb 26. Int J Obes (Lond). 2008. PMID: 18301391 Free PMC article. No abstract available.

5

Literature review of visual representation of the results of benefit-risk assessments of medicinal products.

Hallgreen CE, Mt-Isa S, Lieftucht A, Phillips LD, Hughes D, Talbot S, Asiimwe A, Downey G, Genov G, Hermann R, Noel R, Peters R, Micaleff A, Tzoulaki I, Ashby D; PROTECT Benefit-Risk group. Hallgreen CE, et al. Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):238-50. doi: 10.1002/pds.3880. Epub 2015 Nov 2. Pharmacoepidemiol Drug Saf. 2016. PMID: 26521865 Free article. Review.

6

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.

Mt-Isa S, Hallgreen CE, Wang N, Callréus T, Genov G, Hirsch I, Hobbiger SF, Hockley KS, Luciani D, Phillips LD, Quartey G, Sarac SB, Stoeckert I, Tzoulaki I, Micaleff A, Ashby D; IMI-PROTECT benefit-risk participants. Mt-Isa S, et al. Among authors: hallgreen ce. Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):667-78. doi: 10.1002/pds.3636. Epub 2014 May 13. Pharmacoepidemiol Drug Saf. 2014. PMID: 24821575 Review.

7

The effectiveness of direct to healthcare professional communication - A systematic review of communication factor studies.

Møllebæk M, Kaae S, De Bruin ML, Callréus T, Jossan S, Hallgreen CE. Møllebæk M, et al. Among authors: hallgreen ce. Res Social Adm Pharm. 2019 May;15(5):475-482. doi: 10.1016/j.sapharm.2018.06.015. Epub 2018 Jun 21. Res Social Adm Pharm. 2019. PMID: 31130181

8

Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018.

Højer MG, De Bruin ML, Boskovic A, Hallgreen CE. Højer MG, et al. Among authors: hallgreen ce. BMJ Open. 2020 May 11;10(5):e036498. doi: 10.1136/bmjopen-2019-036498. BMJ Open. 2020. PMID: 32398337 Free PMC article.

9

Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges.

Ofori-Asenso R, Hallgreen CE, De Bruin ML. Ofori-Asenso R, et al. Among authors: hallgreen ce. Front Med (Lausanne). 2020 Oct 16;7:582634. doi: 10.3389/fmed.2020.582634. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33178721 Free PMC article. Review.

10

Impact of regulatory interventions to restrict the combined use of renin-angiotensin system blockers: A Danish nationwide drug utilisation study.

Sindahl P, Ofori-Asenso R, Hallgreen CE, Kemp K, Gardarsdottir H, De Bruin ML. Sindahl P, et al. Among authors: hallgreen ce. Br J Clin Pharmacol. 2022 Mar;88(3):1379-1384. doi: 10.1111/bcp.15080. Epub 2021 Oct 8. Br J Clin Pharmacol. 2022. PMID: 34519065 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters